Prognostic Value of CD133 and SOX2 Expression After Neoadjuvant Chemotherapy in Patients With Locally Advanced Gastric Cancer
The CD133 and SOX2 expression levels after neoadjuvant chemotherapy are independent predictors of survival in locally advanced GC patients receiving neoadjuvant chemotherapy, and higher CD133 and SOX2 expression levels were associated with lower mortality rates.
Authors
- Hailong Jin (ORCID: https://orcid.org/0000-0002-2513-6540)
- Jiren Yu (ORCID: https://orcid.org/0000-0002-7904-107X)
- Xiaosun Liu (ORCID: https://orcid.org/0000-0002-8932-2385)
- Dong Yang (ORCID: https://orcid.org/0000-0002-1971-7349)
- Qing Zhang (ORCID: https://orcid.org/0000-0003-3713-4785)
- Kankai Zhu (ORCID: https://orcid.org/0000-0002-8195-6578)
- Chunhui Shou
Institutions
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- Asia-Pacific Journal of Clinical Oncology
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1111/ajco.14160
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00